In our patient, the most plausible triggers were pelvic radiotherapy and prior urothelial carcinoma, with additional possible contribution from an autoimmune mechanism suggested by the positive ANA titer and markedly elevated inflammatory markers. The gene discussed is BTG3; the disease is urothelial carcinoma.